Prospective clinical trials evaluating artificial intelligence in cardiovascular medicine: A scoping review

Back

ESC Professional Premium Access

Prospective clinical trials evaluating artificial intelligence in cardiovascular medicine: A scoping review

Session: Machine learning for cardiovascular risk assessment: from the heart to the brain

Topic: Artificial Intelligence

Speaker: Ms T. Pequignot (Basel, CH)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Ms Tiffany Pequignot

Cardiovascular Research Institute Basel, Basel (Switzerland)

0 follower

5 more presentations in this session

Artificial intelligence and machine learning for predicting mitral regurgitation risk following NeoChord procedure

Speaker: Doctor F. Serra (Padova, IT)

AI-based identification of acute cellular rejection in digital pathology images of endomyocardial biopsies from heart transplanted patients

Speaker: Mr E. Buccieri (Pavia, IT)

Unravelling the progression of hypertrophic cardiomyopathy: computational insights into MYH7 mutations, ionic remodelling, hypertrophy, and targeted therapy development

Speaker: Doctor A. Hasaballa (Oxford, GB)

One view to rule them all? Applying artificial intelligence to assess valvular disease and ventricular function using a single apical 4-chamber echocardiographic view

Speaker: Doctor L. Fisher (Ramat Gan, IL)

Role of neuropsychiatric treatments and conditions in young SCA patients using IA.

Speaker: Professor X. Jouven (Paris, FR)

Access the full session

Machine learning for cardiovascular risk assessment: from the heart to the brain

Speakers: Ms T. Pequignot, Doctor F. Serra, Mr E. Buccieri, Doctor A. Hasaballa, Doctor L. Fisher...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources